Skip to main content

Agilent Buys Automated Lab Technologies Company Velocity11

NEW YORK (GenomeWeb News) – Agilent Technologies said yesterday that it has inked a deal to buy Velocity11, a private life science lab technology company, for an undisclosed sum.
Agilent believes the acquisition will strengthen its automated sample-preparation offerings across a broad range of applications.
Velocity11 designs, makes, and markets robotic solutions including stand-alone, bench-top, and multi-armed robotic systems. The company also markets software designed to control the robotics in its products.
Agilent said it would offer jobs to “substantially all of Velicity11’s approximately 150 employees worldwide.”
Velocity11 is based in Menlo Park, Calif., with a second office in Melbourn, Hertfordshire, UK, and has field sales and support “throughout the US and Western Europe.”
Nick Roelofs, Agilent's VP of life science systems and solutions, said the acquisition will help the firm offer automated solutions that can “speed drug discovery and genetic research.”
Financial terms of the agreement were not released.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.